Naoko Shimada

Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.

Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors.

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.

Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.

Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.

Cerebral infarction in advanced non-small cell lung cancer: a case control study.

Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.

Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.

LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer.

A method of high-throughput functional evaluation of gene variants of unknown significance in cancer.

Malignant Pleural Mesothelioma with Bone Marrow Metastases.

Age is an independent predictor in pathological diagnosis of sarcoidosis: a retrospective analysis of diagnosis by endobronchial ultrasound-guided transbronchial needle aspiration.